PF-Atlas › Clinical Trials › NCT03485092
Studies of Empagliflozin and Its Cardiovascular, Renal and Metabolic Effects
Empagliflozin 10 MG · Phase 4
Registry ID
NCT03485092
Phase
Phase 4
Status
Completed
Drug / intervention
Empagliflozin 10 MG
Sponsor
NHS Greater Glasgow and Clyde
Start
2018-03-16
About this trial
Empagliflozin 10 MG is evaluated in NCT03485092, a Phase 4 idiopathic pulmonary fibrosis study sponsored by NHS Greater Glasgow and Clyde. Current status: Completed.
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT03485092 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.